Zobrazeno 1 - 10 of 838 pro vyhledávání: '"Matharu L"'
1
Akademický článek
Cost-effectiveness of leveraging existing HIV primary health systems and community health workers for hypertension screening and treatment in Africa: an individual-based modelling study.
Autor: Hickey MD; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, United States., Ayieko J; Kenya Medical Research Institute, Nairobi, Kenya., Kabami J; Infectious Diseases Research Collaboration, Kampala, Uganda., Owaraganise A; Infectious Diseases Research Collaboration, Kampala, Uganda., Kakande E; Infectious Diseases Research Collaboration, Kampala, Uganda., Ogachi S; Kenya Medical Research Institute, Nairobi, Kenya., Aoko CI; Kenya Medical Research Institute, Nairobi, Kenya., Wafula E; Kenya Medical Research Institute, Nairobi, Kenya., Sang N; Kenya Medical Research Institute, Nairobi, Kenya., Sunday H; Infectious Diseases Research Collaboration, Kampala, Uganda., Revill P; Centre for Health Economics, University of York, York, United Kingdom., Bansi-Matharu L; Institute for Global Health, University College London, London, United Kingdom., Shade SB; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, United States., Chamie G; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, United States., Balzer LB; School of Public Health, University of California, Berkeley, Berkeley, United States., Petersen M; School of Public Health, University of California, Berkeley, Berkeley, United States., Havlir DV; Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, United States., Kamya MR; Infectious Diseases Research Collaboration, Kampala, Uganda.; Department of Medicine, Makerere University, Kampala, Uganda., Phillips AN; Institute for Global Health, University College London, London, United Kingdom.
Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2024 Nov 26. Date of Electronic Publication: 2024 Nov 26.
Zobrazit plný text záznamu
2
Akademický článek
The effect on HIV transmission and cost-effectiveness of programmes for female sex workers in East, Central, and Southern Africa: a modelling study.
Autor: Bansi-Matharu L; Institute for Global Health, University College London, London, UK. Electronic address: l.bansi-matharu@ucl.ac.uk., Revill P; Centre for Health Economics, University of York, York, UK., Taramusi I; National AIDS Council, Harare, Zimbabwe., Steen R; Department of Public Health, Erasmus University, Rotterdam, Netherlands., Chabata ST; Centre for Sexual Health and HIV AIDS Research (CESHHAR) Zimbabwe, Harare, Zimbabwe., Busza J; Department of Population Health, London School of Hygiene & Tropical Medicine, London, UK., Mangenah C; Centre for Sexual Health and HIV AIDS Research (CESHHAR) Zimbabwe, Harare, Zimbabwe; International Public Health Department, Liverpool School of Tropical Medicine, Liverpool, UK., Musemburi S; Centre for Sexual Health and HIV AIDS Research (CESHHAR) Zimbabwe, Harare, Zimbabwe., Machingura F; Centre for Sexual Health and HIV AIDS Research (CESHHAR) Zimbabwe, Harare, Zimbabwe., Desmond N; International Public Health Department, Liverpool School of Tropical Medicine, Liverpool, UK; Malawi-Liverpool Wellcome Trust Clinical Research Programme, Liverpool School of Tropical Medicine, Blantyre, Malawi., Matambanadzo P; Centre for Sexual Health and HIV AIDS Research (CESHHAR) Zimbabwe, Harare, Zimbabwe., Shahmanesh M; Institute for Global Health, University College London, London, UK; Clinical Research Department, Africa Health Research Institute, Mtubatuba, South Africa., Yekeye R; National AIDS Control Programme, Harare, Zimbabwe., Mugurungi O; AIDS and TB Directorate, Ministry of Health and Child Care, Harare, Zimbabwe., Cowan FM; Centre for Sexual Health and HIV AIDS Research (CESHHAR) Zimbabwe, Harare, Zimbabwe; International Public Health Department, Liverpool School of Tropical Medicine, Liverpool, UK., Hargreaves JR; Department of Population Health, London School of Hygiene & Tropical Medicine, London, UK., Phillips AN; Institute for Global Health, University College London, London, UK.
Publikováno v: The Lancet. Global health [Lancet Glob Health] 2024 Sep; Vol. 12 (9), pp. e1436-e1445.
Zobrazit plný text záznamu
3
Akademický článek
A risk-differentiated, community-led intervention to strengthen uptake and engagement with HIV prevention and care cascades among female sex workers in Zimbabwe (AMETHIST): a cluster randomised trial.
Autor: Cowan FM; Department of International Health, Liverpool School of Tropical Medicine, Liverpool, UK; Centre for Sexual Health and HIV AIDS Research (CeSHHAR) Zimbabwe, Harare, Zimbabwe. Electronic address: frances.cowan@lstmed.ac.uk., Machingura F; Centre for Sexual Health and HIV AIDS Research (CeSHHAR) Zimbabwe, Harare, Zimbabwe., Ali MS; Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK., Chabata ST; Centre for Sexual Health and HIV AIDS Research (CeSHHAR) Zimbabwe, Harare, Zimbabwe., Takaruza A; Centre for Sexual Health and HIV AIDS Research (CeSHHAR) Zimbabwe, Harare, Zimbabwe., Dirawo J; Centre for Sexual Health and HIV AIDS Research (CeSHHAR) Zimbabwe, Harare, Zimbabwe., Makamba M; Centre for Sexual Health and HIV AIDS Research (CeSHHAR) Zimbabwe, Harare, Zimbabwe., Hove T; Centre for Sexual Health and HIV AIDS Research (CeSHHAR) Zimbabwe, Harare, Zimbabwe., Bansi-Matharu L; Institute of Global Health, University College London, London, UK., Matambanadzo P; Centre for Sexual Health and HIV AIDS Research (CeSHHAR) Zimbabwe, Harare, Zimbabwe., Shahmanesh M; Institute of Global Health, University College London, London, UK; Africa Health Research Institute, Durban, South Africa., Busza J; Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK., Steen R; Department of International Health, Liverpool School of Tropical Medicine, Liverpool, UK., Yekeye R; National AIDS Council, Harare, Zimbabwe., Mpofu A; National AIDS Council, Harare, Zimbabwe., Mugurungi O; Directorate of AIDS and TB, Ministry of Health and Child Care, Harare, Zimbabwe., Phillips AN; Institute of Global Health, University College London, London, UK., Hargreaves JR; Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK.
Publikováno v: The Lancet. Global health [Lancet Glob Health] 2024 Sep; Vol. 12 (9), pp. e1424-e1435.
Zobrazit plný text záznamu
4
Akademický článek
Integrase strand transfer inhibitor (INSTI) related changes in BMI and risk of diabetes: a prospective study from the RESPOND cohort consortium.
Autor: Rupasinghe D; The Australian HIV Observational Database (AHOD), The Kirby Institute, UNSW Sydney, Australia., Bansi-Matharu L; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK., Law M; The Australian HIV Observational Database (AHOD), The Kirby Institute, UNSW Sydney, Australia., Zangerle R; Austrian HIV Cohort Study (AHIVCOS), Medizinische Universität Innsbruck, Innsbruch, Austria., Rauch A; Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Switzerland., Tarr PE; Swiss HIV Cohort Study (SHCS), University Department of Medicine, Kantonsspital Baselland, University of Basel, Switzerland., Greenberg L; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK., Neesgaard B; CHIP, Section 2100, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Jaschinski N; CHIP, Section 2100, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., De Wit S; CHU Saint-Pierre, Centre de Recherche en Maladies Infectieuses a.s.b.l., Brussels, Belgium., Wit F; AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort, HIV Monitoring Foundation, Amsterdam, the Netherlands., Monforte AD; Italian Cohort Naive Antiretrovirals (ICONA), ASST Santi Paolo e Carlo, Milano, Italy., Fontas E; Nice HIV Cohort, Université Côte d'Azur et Centre Hospitalier Universitaire, Nice, France., Castagna A; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy., Stecher M; University Hospital Cologne, Cologne, Germany., Brandes V; University Hospital Cologne, Cologne, Germany., Florence E; Institute of Tropical Medicine, Antwerp, Belgium.; University Hospital, Antwerp, Belgium., Begovac J; University Hospital for Infectious Diseases, Zagreb, Croatia., Mussini C; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy., Sönnerborg A; Swedish InfCare HIV Cohort, Karolinska University Hospital., Abutidze A; Georgian National AIDS Health Information System (AIDS HIS), Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia., Groh A; Frankfurt HIV Cohort Study, Johann Wolfgang Goethe-University Hospital, Frankfurt, Germany., Vannappagari V; ViiV Healthcare, RTP, North Carolina, USA., Cohen C; Gilead Sciences,  Foster City, California., Young L; Merck & Co. (MSD), Whitehouse Station,  United States., Hosein S; European AIDS Treatment Group (EATG)., Ryom L; CHIP, Section 2100, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Infectious Diseases, Hvidovre University Hospital, Denmark.; Department of Clinical Medicine, University of Copenhagen, Denmark., Petoumenos K; The Australian HIV Observational Database (AHOD), The Kirby Institute, UNSW Sydney, Australia.
Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Aug 09. Date of Electronic Publication: 2024 Aug 09.
Zobrazit plný text záznamu
5
Akademický článek
Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts.
Autor: Byonanebye DM; Kirby Institute, University of New South Wales, Kensington, NSW, Australia; School of Public Health, Makerere University, Kampala, Uganda. Electronic address: dbyonanebye@musph.ac.ug., Polizzotto MN; The Australian National University, Canberra, ACT, Australia., Maltez F; Hospital Curry Cabral, Lisbon, Portugal., Rauch A; Department of Infectious Diseases, Inselspital, Bern University Hospital, Bern, Switzerland., Grabmeier-Pfistershammer K; Medizinische Universität Wien, Vienna, Austria., Wit F; Stichting HIV Monitoring, Amsterdam, Netherlands., De Wit S; Department of Infectious Diseases, St Pierre University Hospital Bruxelles, Université Libre de Bruxelles, Brussels, Belgium., Castagna A; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milan, Italy., d'Arminio Monforte A; ASST Santi Paolo e Carlo, Milan, Italy., Mussini C; Università degli Studi di Modena, Modena, Italy., Wasmuth JC; University Hospital Bonn, Bonn, Germany., Fontas E; Nice HIV cohort, Université Côte d'Azur et Centre Hospitalier Universitaire, Nice, France., Abela I; University of Zurich, Zurich, Switzerland; University Hospital of Zurich, Zurich, Switzerland., Sarcletti M; Department of Dermatology, Venerology, and Allergology, Medical University Innsbruck, Innsbruck, Austria., Bansi-Matharu L; Center for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK., Jaschinski N; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Peters L; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Hosein SR; European AIDS Treatment Group, Brussels, Belgium., Vannappagari V; ViiV Healthcare, Durham, NC, USA., Cohen C; Gilead Sciences, Foster City, CA, USA., Bissio E; Merck Sharp & Dohme, Madrid, Spain., Mocroft A; Center for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, UK; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Law M; Kirby Institute, University of New South Wales, Kensington, NSW, Australia., Ryom L; CHIP, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Petoumenos K; Kirby Institute, University of New South Wales, Kensington, NSW, Australia.
Publikováno v: The lancet. HIV [Lancet HIV] 2024 May; Vol. 11 (5), pp. e321-e332. Date of Electronic Publication: 2024 Apr 12.
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents
Autor: Byonanebye D. M., Polizzotto M. N., Begovac J., Grabmeier-Pfistershammer K., Abela I., Castagna A., de Wit S., Mussini C., Vehreschild J. J., d'Arminio Monforte A., Wit F. W. N. M., Pradier C., Chkhartishvili N., Sonnerborg A., Hoy J., Lundgren J., Neesgaard B., Bansi-Matharu L., Greenberg L., Llibre J. M., Vannappagari V., Gallant J., Necsoi C., Cichon P., Reiss P., Aho I., Tsertsvadze T., Mennozzi M., Rauch A., Muccini C., Law M., Mocroft A., Ryom L., Petoumenos K., Hillebregt M., Rose N., Zangerle R., Appoyer H., Delforge M., Wandeler G., Stephan C., Bucht M., Chokoshvili O., Rodano A., Tavelli A., Fanti I., Borghi V., Fontas E., Dollet K., Caissotti C., Casabona J., Miro J. M., Smith C., Lampe F., Johnson M., Burns F., Chaloner C., Lazzarin A., Poli A., Falconer K., Svedhem V., Gunthard H., Ledergerber B., Bucher H., Scherrer A., Wasmuth J. C., Rockstroh J., Fatkenheuer G., Stecher M., Schulze N., Franke B., Rooney J., Rogatto F., Garges H., Kowalska J., Raben D., Peters L., Anne A. V., Dedes N., Williams E. D., Bruguera A., Haubrich R., Svedhem-Johansson V., Bloch M., Braun D., Calmy A., Schuttfort G., Youle M., Zona S., Antinori A., Bolokadze N., Schwarze-Zander C., Duvivier C., Dragovic G., Radoi R., Oprea C., Vasylyev M., Matulionyte R., Mulabdic V., Marchetti G., Kuzovatova E., Coppola N., Martini S., Harxhi A., Waehre T., Pharris A., Vassilenko A., Bogner J., Maagaard A., Jablonowska E., Elbirt D., Marrone G., Leen C., Wyen C., Kundro M., Thorpe D., Volny-Anne A., Mendao L., Larsen J. F., Jakobsen M. L., Bruun T., Bojesen A., Hansen E. V., Elsing T. W., Kristensen D., Thomsen S., Weide T., Pelchen-Matthews A.
Publikováno v: AIDS. 35:869-882
Objective: To compare the incidence of dyslipidemia in people with HIV receiving integrase inhibitors (INSTI) versus boosted protease inhibitors (PI/b) and nonnucleoside reverse transcriptase inhibitors (NNRTI) within RESPOND consortium of prospectiv
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ada09d6722277e4169123e80328e9c2
https://doi.org/10.1097/qad.0000000000002811
Zobrazit plný text záznamu
10
Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium
Autor: Byonanebye, Dathan M., Polizzotto, Mark N., Neesgaard, Bastian, Sarcletti, Mario, Matulionyte, Raimonda, Braun, Dominique L., Castagna, Antonella, de Wit, Stéphane, Wit, Ferdinand, Fontas, Eric, Vehreschild, J. rg Janne, Vesterbacka, Jan, Greenberg, Lauren, Hatleberg, Camilla, Garges, Harmony, Gallant, Joel, Volny Anne, Alain, Öllinger, Angela, Mozer-Lisewska, Iwona, Surial, Bernard, Spagnuolo, Vincenzo, Necsoi, Coca, van der Valk, Marc, Mocroft, Amanda, Law, Matthew, Ryom, Lene, Petoumenos, Kathy, Hillebregt, M., Rose, N., Hutchinson, J., Zangerle, R., Appoyer, H., Delforge, M., Stephan, C., Bucht, M., Chkhartishvili, N., Chokoshvili, O., Mussini, C., Borghi, V., Pradier, C., Dollet, K., Caissotti, C., Casabona, J., Miro, J. M., Smith, C., Lampe, F., Johnson, M., Burns, F., Chaloner, C., Lazzarin, A., Poli, A., Sönnerborg, A., Falconer, K., Svedhem, V., Günthard, H., Ledergerber, B., Bucher, H., Scherrer, A., Wasmuth, J. C., Rockstroh, J., Fätkenheuer, G., Stecher, M., Schulze, N., Franke, B., Rooney, J., McNicholl, I., Vannappagari, V., Wandeler, G., Lundgren, J., Kowalska, J., Raben, D., Mocroft, A., Peters, L., Williams, E. D., Necsoi, C., D’Arminio Monforte, A., Bruguera, A., Dedes, Nikos, Mendao, Luis, Larsen, J. F., Jaschinski, N., Jakobsen, M. L., Bruun, T., Bojesen, A., Hansen, E. V., Traytel, A. K., Elsing, T. W., Kristensen, D., Weide, T., Bansi-Matharu, L., Pelchen-Matthews, A.
Publikováno v: The Respond Study Group 2022, ' Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium ', HIV Medicine, vol. 23, no. 8, pp. 895-910 . https://doi.org/10.1111/hiv.13273
Byonanebye, Dathan M; Polizzotto, Mark N; Neesgaard, Bastian; Sarcletti, Mario; Matulionyte, Raimonda; Braun, Dominique L; Castagna, Antonella; de Wit, Stéphane; Wit, Ferdinand; Fontas, Eric; Vehreschild, Jörg Janne; Vesterbacka, Jan; Greenberg, Lauren; Hatleberg, Camilla; Garges, Harmony; Gallant, Joel; Volny Anne, Alain; Öllinger, Angela; Mozer-Lisewska, Iwona; Surial, Bernard; ... (2022). Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium. HIV medicine, 23(8), pp. 895-910. Wiley 10.1111/hiv.13273
HIV medicine, Hoboken : Wiley, 2022, vol. 23, iss. 8, p. 895-910
HIV medicine, 23(8), 895-910. Wiley-Blackwell
OBJECTIVE To compare the incidence of hypertension in people living with HIV receiving integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) versus non-nucleoside reverse transcriptase inhibitors (NNRTIs) or boosted protease
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb7897a1a4d6568b14e9dd963676a818
https://pubmed.ncbi.nlm.nih.gov/35233903
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje